About Manifold Bio
Manifold Bio is positioned to be the leading tissue-specific medicines company. We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Our engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Boston, United States
Tracked Since
Sep 30, 2026
Web & Domain Identity
Official Website
manifold.bio
Domain Registered Date
Sep 22, 2018
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $40,000,000 · Series-A
startupintros.com
- Capital Raise
Raised $5,000,000 · Seed
startupintros.com
- Milestone
X account created (@ManifoldBio)
2.2K followers
- Milestone
Website domain registered
manifold.bio
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Manifold Bio.
Funding History
Series-A
· Jun 1, 2022
$40,000,000 startupintros.com
Seed
· Sep 1, 2020
$5,000,000 startupintros.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026